SCHEMBL509440

SCHEMBL509440

Cc1cc(C)c(CC(=O)O)c(C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.58
MAPT P10636 4/20 0.58
POLB P06746 1/20 0.58
TSHR P16473 2/20 0.49
HPGD P15428 1/20 0.49
GAA P10253 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
SLC22A12 Q96S37 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
TPMT P51580 1/20 0.41
AKR1B1 P15121 1/20 0.40
SRC P12931 1/20 0.40
AGBL2 Q5U5Z8 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GPR17 Q13304 1/20 0.40
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL28215001 0.98 KDM4E (0.56) KDM4EMAPTPOLBTSHRHPGD
Hydrochloric Acid SCHEMBL2529687 0.98 KDM4E (0.56) KDM4EMAPTPOLBTSHRHPGD
Dioxane SCHEMBL28219405 0.88 KDM4E (0.49) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL510475 0.86 MAPT (0.50) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL22066831 0.86 KDM4E (0.50) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL510473 0.86 KDM4E (0.50) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL508942 0.86 KDM4E (0.50) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL9780872 0.84 CYP3A4 (0.47) KDM4EMAPTPOLBGAAMEN1
SCHEMBL12214120 0.83 KDM4E (0.42) KDM4EMAPTPOLBTSHRHPGD
SCHEMBL510321 0.82 KDM4E (0.47) KDM4EMAPTPOLBTSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850059-B Improved synthesis process of 2,4, 6-trimethylphenylacetyl chloride 大连奇凯医药科技有限公司 2024-03-22 CN claimed
CN-114394895-B Preparation method of 2,4, 6-trimethylphenylacetic acid 西安凯立新材料股份有限公司 2023-09-15 CN claimed
CN-115850059-A Improved synthesis process of 2,4, 6-trimethylbenzene acetyl chloride 大连奇凯医药科技有限公司 2023-03-28 CN claimed
CN-114394895-A Preparation method of 2,4, 6-trimethylphenylacetic acid 西安凯立新材料股份有限公司 2022-04-26 CN claimed
US-9783654-B2 Additives and methods for terminating polymerization and/or reducing viscosity of polymer solution CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-10-10 US claimed
US-20130158174-A1 ADDITIVES AND METHODS FOR TERMINATING POLYMERIZATION AND/OR REDUCING VISCOSITY OF POLYMER SOLUTION BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) 2013-06-20 US claimed
EP-0665212-B1 Process for the preparation of 2,4,6-trimethylphenylacetic acid BAYER AG (DE) 1999-06-09 EP claimed
US-20260068886-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL OERTH BIO LLC (US) 2026-03-12 US disclosed
WO-2024050016-A9 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL OERTH BIO LLC (US) 2025-04-03 WO disclosed
CN-115850059-B Improved synthesis process of 2,4, 6-trimethylphenylacetyl chloride 大连奇凯医药科技有限公司 2024-03-22 CN disclosed
WO-2024050016-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL OERTH BIO LLC (US) 2024-03-07 WO disclosed
CN-114394895-B Preparation method of 2,4, 6-trimethylphenylacetic acid 西安凯立新材料股份有限公司 2023-09-15 CN disclosed
CN-114394895-B Preparation method of 2,4, 6-trimethylphenylacetic acid 西安凯立新材料股份有限公司 2023-09-15 CN disclosed
WO-1996030339-A1 PYRROLIDINYL HYDROXAMIC ACID COMPOUNDS AND THEIR PRODUCTION PROCESS PFIZER INC. (US) 1996-10-03 WO disclosed
EP-0698010-A1 N-ACYL SULFAMIC ACID ESTERS (OR THIOESTERS), N-ACYL SULFONAMIDES, AND N-SULFONYL CARBAMIC ACID ESTERS (OR THIOESTERS) AS HYPERCHOLESTEROLEMIC AGENTS WARNER-LAMBERT COMPANY (US) 1996-02-28 EP disclosed
US-5491172-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1996-02-13 US disclosed
EP-0676388-A2 Process for the preparation of phenylacetic acid derivatives and intermediate products BAYER AG (DE) 1995-10-11 EP disclosed
WO-1994026702-A1 N-ACYL SULFAMIC ACID ESTERS (OR THIOESTERS), N-ACYL SULFONAMIDES, AND N-SULFONYL CARBAMIC ACID ESTERS (OR THIOESTERS) AS HYPERCHOLESTEROLEMIC AGENTS WARNER-LAMBERT COMPANY (US) 1994-11-24 WO disclosed
EP-0528156-A1 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives BAYER AG (DE) 1993-02-24 EP disclosed
US-4544450-A Electrochemical process for the synthesis of organic compounds ANIC S.P.A. (IT) 1985-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068886-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL CRBN, STUB1, CUL1 KDM4E 928/4885MAPT 3939/4885POLB 3235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.